Group

Latest News

13 December, 2018

Taipeibio was selected by MOST and LSN to present in the Taiwan Luncheon company pitch at RESI JPM (JP Morgan) 2019 in San Francisco, USA.

5 November, 2018

T Bio Inc. (Cayman) & Taipebio join 2018 RESI New York events

18 October, 2018

Welcome Life Science Nation CEO Dennis & VP Greg at Taipeibio Lab 2.

About Us

Taipeibio is an R&D-oriented company with core technology derived from Harvard and MIT; which focuses on tissue engineering. Our technology covers specialties for bone & joint regeneration, such as TMJ and the critical-sized bone defect repair.

Latest Articles

Effects of collagen matrix and bioreactor cultivation on cartilage regeneration.

PLoS One. 2018 May 10;13(5):e0196779.

Optical imaging of ovarian cancer.

PLoS One. 2018 Feb 1;13(2):e0192047.

Repair of the TMJ Disc in Rabbit.

Materials (Basel). 2017 Aug 9;10(8).

Latest Shows & Exhibitions

RESI SAN FRANCISCO 2019.

2018 BIO International Convention.

RESI (Redefine Early Stage Innovation) Boston 2018.